Aeterna Zentaris Provides Business Update and Outlines Key Upcoming Milestones

Provided By Globe Newswire

Last update: Jan 17, 2023

TORONTO, ONTARIO, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products, today provided a business update and outlined upcoming key milestones.